| Views | |
|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 535 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies | 18 | 13 | 0 | 7 | 8 | 3 | 6 |
| Views | |
|---|---|
| Dissertation_P.Mehlitz_2016.pdf | 310 |
